Literature DB >> 14728707

Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0.

S W Powers1, S R Patton, K A Hommel, A D Hershey.   

Abstract

The aim of this study was to measure quality of life (QOL) across a broad age range of paediatric migraine patients. Children and adolescents (n=686) with migraine completed the Pediatric Quality of Life Inventory, version 4.0 (PedsQL 4.0) and a standardized headache assessment at an initial clinic visit. The sample size for each PedsQL age group was: age 2-4=21, age 5-7=86, age 8-12=298, and age 13-18=281. Mean total score was 72.7 +/- 14.8, significantly less than healthy norms (P<0.01). Teens reported lower School Functioning than older and young children (P<0.05) and young children reported lower Social Functioning than older children and teens (P<0.001). A moderate relation was found between self and parent report. Age-related effects on QOL have implications for the evaluation and management of migraine in paediatric practice. The self and parent report forms of the PedsQL can be used in a practice setting.

Entities:  

Mesh:

Year:  2004        PMID: 14728707     DOI: 10.1111/j.1468-2982.2004.00652.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  37 in total

Review 1.  New Developments in the Prophylactic Drug Treatment of Pediatric Migraine: What Is New in 2017 and Where Does It Leave Us?

Authors:  Joanne Kacperski; Allyson Bazarsky
Journal:  Curr Pain Headache Rep       Date:  2017-08

2.  Health-related quality of life and cognitive functioning from the perspective of parents of school-aged children with Asperger's Syndrome utilizing the PedsQL.

Authors:  Christine A Limbers; Robert W Heffer; James W Varni
Journal:  J Autism Dev Disord       Date:  2009-06-13

Review 3.  Preventive drugs in childhood and adolescent migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2014-06

4.  Intranasal sumatriptan for migraine in children.

Authors:  Ran D Goldman; Garth D Meckler
Journal:  Can Fam Physician       Date:  2015-05       Impact factor: 3.275

5.  Symptoms and quality of life indicators among children with chronic medical conditions.

Authors:  Jiseon Kim; Hyewon Chung; Dagmar Amtmann; Rana Salem; Ryoungsun Park; Robert L Askew
Journal:  Disabil Health J       Date:  2013-10-12       Impact factor: 2.554

6.  The treatment of migraine headaches in children and adolescents.

Authors:  Michelle Brenner; Donald Lewis
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

7.  Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study.

Authors:  Margaret F Keil; Deborah P Merke; Roma Gandhi; Edythe A Wiggs; Kathy Obunse; Constantine A Stratakis
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-17       Impact factor: 3.478

8.  Health related quality of life in 10-year-old schoolchildren.

Authors:  Camilla Laaksonen; Minna Aromaa; Olli J Heinonen; Leena Koivusilta; Pasi Koski; Sakari Suominen; Tero Vahlberg; Sanna Salanterä
Journal:  Qual Life Res       Date:  2008-09-12       Impact factor: 4.147

Review 9.  Classification of pediatric headache.

Authors:  Paul Winner
Journal:  Curr Pain Headache Rep       Date:  2008-10

10.  Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.

Authors:  Andrew D Hershey; Scott W Powers; Christopher S Coffey; Dixie D Eklund; Leigh Ann Chamberlin; Leslie L Korbee
Journal:  Headache       Date:  2013-04-17       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.